期刊文献+

应用抗菌药物导致医院感染发生的控制措施 被引量:7

Nosocomial Infection in Patients: Control Measures
下载PDF
导出
摘要 目的为控制因抗菌药物滥用导致医院感染的发生,研究有效措施,加强对医院临床科室感染病原菌的监控,预防发生医源性医院感染。方法采用纵向分析方法,对2000年7-12月与2002年7-12月医院信息报表及住院患者住院病历进行回顾性调查;并前瞻性针对抗菌药物使用不合理存在的问题进行分析,采取相应措施控制医院感染的发生,并于两年后同期监测相关控制指标。结果通过定期监控及纵向同期分析比较,医院感染发生在采取控制措施前后,临床各科室医院感染发生率呈现明显变化趋势。结论医院对抗菌药物的控制管理应强化监控措施,强化的重点应从抗菌药物的采购、临床应用指征、监测及信息反馈等环节,从而有效、合理地使用抗菌药物,控制医院感染发生率。 OBJECTIVE To give a general introduction to the infection in the hospital, and supervision to key departments in order to prevent nosocomial infection occurrence. METHODS A vertical analysis was made on the basis of the survey involving the following three periods: the first period covered the second half of the year 2000 (from Jul to Dec 2000), the second period covered the second half of the year 2002 (from Jul to Dec 2002), and the third period covered the second half of the year 2004 (from Jul to Dec 2004). RESULTS The periodical supervision and the vertical analysis in the same period showed the following: the rates of the infected patients in the departments showing a tend to go on rising from 2000 to 2002, and showing a tend to decline from 2002 to 2004. CONCLUSIONS The control of using antibiotics must be emphasized and they should be applied in a scientific and reasonable way. The key points include the management of purchasing drugs, clinical indications and usages, supervise and news feedback, etc. All of these measures could prevent the occurrence of nosocomial infection effectively.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2006年第12期1397-1399,共3页 Chinese Journal of Nosocomiology
关键词 医院感染 抗菌药物 控制系统 Nosocomial infection Antibiotics Control system
  • 相关文献

参考文献7

二级参考文献25

  • 1王睿,周琦,孙效东,王淑敏,高碧珍,叶林阳.医院感染危险因素分析[J].中华医院感染学杂志,1992,2(3):162-164. 被引量:10
  • 2刘俊.医疗费用“总量控制 结构调整”政策实施的效果和社会影响[J].中华医院管理杂志,1995,11(9):516-521. 被引量:32
  • 3陈增辉,巩玉秀,李六亿.我国医院感染管理的现状及展望[J].中华医院管理杂志,1995,11(12):717-721. 被引量:88
  • 4戴自英 刘裕昆 等.实用抗菌药物学[M].上海:科学技术出版社,1991.40.
  • 5周海洋 王龙兴 等.“总量控制,结构调整”政策对制药业的健康发展作用析[J].中华医院管理杂志,1995,11(9):534-534.
  • 6..医院感染管理规范[S].中华人民共和国卫生部,2000,15-20..
  • 7[1]Jacoby GA,Mederiros AA. More extended-spectrum β-lactamases[J]. Antimicrob Agents Chemother,1991, 35(9):1697-1704.
  • 8[4]Sanders CC,Barry AL, Washington JA, et al. Detection of extended-spectrum β-lactamases-producing members of the family Enterobacteriaceae with the VITEK ESBLs test [J]. J Clin Microbiol, 1996,34(12): 2997-3001.
  • 9[5]Livermore DM. β-Lactamases in laboratory and clinical resistance [J]. J Clin Microbiol Rev, 1995, 8(3): 557-584.
  • 10[6]National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement [S]. NCCLS, 1999.19: 36-75.

共引文献396

同被引文献35

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部